Abstract
Nitrofurantoin (NFN) radiolabeling with technetium-99m (99mTc) was investigated using different concentration of the NFN, sodium pertechnetate (Na99mTcO4), reducing agent (SnCl2) at different pH ranges (5.1–6.00). The suitability of the 99mTc-NFN was evaluated in terms of the radiochemical purity (RCP) yield, in vitro stability in saline, serum, in vitro binding with E. coli, biodistribution in E. coli infected model rat (ERT), and scintigraphic accuracy in E. coli infected model rabbit (EBT). The superlative radiochemical succumb at 2.5 mg NFN, 125 μL of SnCl2 (1 μg/μL in 0.01 N HCl), 2.5 mCi of Na99mTcO4, at pH 5.2 at 30, 60, 90, and 120 min after reconstitution was 64.50 ± 0.11, 97.50 ± 0.16, 94.25 ± 0.10, 92.15 ± 0.14 and 90.75 ± 0.0.13%. The complex was found stable in saline and serum for 90% up to 120 min and showed 50–65% in vitro binding with E. coli. The absorption of the 99mTc-NFN, primarily at E. Coli infected (ECT) muscle of ERT was lower but after 60 min it went up to 7.25 ± 0.17%. The absorption in the blood, liver, spleen, stomach, intestines, inflamed muscle (N.T1) and normal muscle (N.T2) went down while in the kidney and urine it went up with time. The ratio of the ECT/N.T1 was 7:1 and N.T2/N.T1 was 2:1. The Whole Body Static (WBS) imaging of the ERB confirmed the suitability of the 99mTc-NFN as radiotracer. The superlative radiochemical succumb, significant in vitro stability in saline and serum, in vitro binding with E. coli, ideal biodistribution and scintigraphic accuracy confirmed the viability of the 99mTc-NFN as radiotracer for infection.
Similar content being viewed by others
References
Bar-Shalom R, Yefremov N, Guralnik L, Keidar Z, Engel A, Nitecki S, Israel O (2006) J Nucl Med 47:587
Rusckowski M, Gupta S, Liu G, Dou S, Hnatowich DJ (2004) J Nucl Med 45:1201
Sarda L, Cremieux A, Lebellec Y, Meulemans A, Lebtahi R, Hayem G, Genin R, Delahaye N, Huten D, Guludec DL (2003) J Nucl Med 44:920
Oyen WJG, Boerman OC, Storm G, van Bloois L, Koenders EB, Claessens RAMJ, Perenboom RM, Crommelin DJA, van der Meer JWM, Corstens FHM (1996) J Nucl Med 37:1392
Hong Z, Ning-yi J, Lin Z (2009) Chin Med J 16:1907
Zhang J, Guo H, Zhang S, Lin Y, Wang X (2008) Bioorg Med Chem Lett 18:5168
Motaleb MA (2007) J Radioanal Nucl Chem 272:95
Lumbrecht FY, Yilmaz O, Unak P, Seytigolu B, Durkan K, Baskan H (2008) J Radioanal Nucl Chem 277:491
El-Ghany EA, Amine AM, El-Sayed AS, El-Kolaly MT, Abdel-Gelil F (2005) J Radioanal Nucl Chem 266:125
Roohi S, Mustaq A, Jehangir M, Malik SA (2006) J Radioanal Nucl Chem 267:561
Motaleb MA (2009) J Labelled Comp Radiopharm 52:415
Chattopadhyay S, Das SS, Chandra S, De K, Mishra M, Sarkar BR, Sinha S, Ganguly S (2010) Appl Radiat Isot 68:314
Qaiser SS, Khan AU, Khan MR (2010) J Radioanal Nucl Chem 284:189
Qaiser SS, Khan AU, Khan MR (2010) Appl Radiat Isot. doi:10.1016/j.apradiso.2010.05.014
Lima-Neto P, Correia AN, Portela RR, Juliao MS, Linhares-Junior GF, de Lima JES (2010) Talanta 80:1730
Sastry SS, Jayaraman R (1985) Arch Biochem Biophys 236:252
Welling MM, Lupetti A, Balter HS, Lanzzeri S, Souto B, Rey AM, Savio EO, Paulusma-Annema A, Pauwels EKJ, Nibbering PH (2001) J Nucl Med 42:788
Sharma S, Athar F, Maurya MR, Naqvi F, Azam A (2005) Eur J Med Chem 40:557
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shah, S.Q., Khan, A.U. & Khan, M.R. Radiosynthesis of 99mTc-nitrofurantoin a novel radiotracer for in vivo imaging of Escherichia coli infection. J Radioanal Nucl Chem 287, 417–422 (2011). https://doi.org/10.1007/s10967-010-0697-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-010-0697-z